Zhejiang Runyang New Material Technology Inkomsten in het verleden
Verleden criteriumcontroles 4/6
Zhejiang Runyang New Material Technology's earnings have been declining at an average annual rate of -34.2%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been declining at an average rate of 4.4% per year. Zhejiang Runyang New Material Technology's return on equity is 2.9%, and it has net margins of 10.2%.
Belangrijke informatie
-34.2%
Groei van de winst
-41.7%
Groei van de winst per aandeel
| Chemicals Groei van de industrie | 12.1% |
| Inkomstengroei | -4.4% |
| Rendement op eigen vermogen | 2.9% |
| Nettomarge | 10.2% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
There's Reason For Concern Over Zhejiang Runyang New Material Technology Co., Ltd.'s (SZSE:300920) Price
Sep 27
Zhejiang Runyang New Material Technology Co., Ltd. (SZSE:300920) Surges 29% Yet Its Low P/E Is No Reason For Excitement
May 21Be Wary Of Zhejiang Runyang New Material Technology (SZSE:300920) And Its Returns On Capital
Apr 23Zhejiang Runyang New Material Technology Co., Ltd. (SZSE:300920) Investors Are Less Pessimistic Than Expected
Mar 06Opbrengsten en kosten
Hoe Zhejiang Runyang New Material Technology geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 408 | 42 | 49 | 12 |
| 30 Jun 24 | 406 | 51 | 48 | 11 |
| 31 Mar 24 | 389 | 59 | 47 | 10 |
| 31 Dec 23 | 359 | 42 | 45 | 11 |
| 30 Sep 23 | 324 | 32 | 41 | 15 |
| 30 Jun 23 | 299 | 16 | 39 | 16 |
| 31 Mar 23 | 336 | 13 | 41 | 19 |
| 01 Jan 23 | 390 | 33 | 43 | 22 |
| 30 Sep 22 | 443 | 36 | 48 | 27 |
| 30 Jun 22 | 508 | 65 | 53 | 28 |
| 31 Mar 22 | 514 | 81 | 47 | 27 |
| 01 Jan 22 | 502 | 90 | 44 | 23 |
| 30 Sep 21 | 496 | 107 | 36 | 19 |
| 30 Jun 21 | 486 | 121 | 31 | 18 |
| 31 Mar 21 | 465 | 127 | 34 | 17 |
| 31 Dec 20 | 434 | 127 | 30 | 16 |
| 30 Sep 20 | 403 | 124 | 57 | 23 |
| 31 Dec 19 | 365 | 116 | 32 | 12 |
| 31 Dec 18 | 325 | 87 | 23 | 10 |
| 31 Dec 17 | 168 | 21 | 34 | 8 |
| 30 Jun 17 | 99 | 16 | 11 | 0 |
| 31 Mar 17 | 77 | 11 | 10 | 0 |
| 31 Dec 16 | 56 | 6 | 10 | 0 |
| 30 Sep 16 | 47 | 5 | 9 | 0 |
| 30 Jun 16 | 39 | 3 | 9 | 0 |
| 31 Mar 16 | 35 | 2 | 8 | 0 |
| 31 Dec 15 | 31 | 2 | 7 | 0 |
| 31 Dec 14 | 22 | 0 | 4 | 0 |
| 31 Dec 13 | 16 | 0 | 3 | 0 |
Kwaliteitswinsten: 300920 has high quality earnings.
Groeiende winstmarge: 300920's current net profit margins (10.2%) are higher than last year (9.9%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 300920's earnings have declined by 34.2% per year over the past 5 years.
Versnelling van de groei: 300920's earnings growth over the past year (29.1%) exceeds its 5-year average (-34.2% per year).
Winst versus industrie: 300920 earnings growth over the past year (29.1%) exceeded the Chemicals industry -3.8%.
Rendement op eigen vermogen
Hoge ROE: 300920's Return on Equity (2.9%) is considered low.